Found: 55
Select item for more details and to access through your institution.
IgG reactivity to different desmoglein-3 ectodomains in pemphigus vulgaris: novel panels for assessing disease severity.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1469937
- By:
- Publication type:
- Article
A case of hidroacanthoma simplex with new dermoscopic features.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Evaluating the efficacy and safety of topical sirolimus 0.2% cream as adjuvant therapy with pulsed dye laser for the treatment of port wine stain: A randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Journal of Cosmetic Dermatology, 2021, v. 20, n. 8, p. 2498, doi. 10.1111/jocd.13867
- By:
- Publication type:
- Article
Remdesivir: A beacon of hope from Ebola virus disease to COVID‐19.
- Published in:
- Reviews in Medical Virology, 2020, v. 30, n. 6, p. 1, doi. 10.1002/rmv.2133
- By:
- Publication type:
- Article
Single‐nucleotide polymorphisms associated with pemphigus vulgaris: Potent markers for better treatment and personalized medicine.
- Published in:
- International Journal of Immunogenetics, 2020, v. 47, n. 1, p. 41, doi. 10.1111/iji.12451
- By:
- Publication type:
- Article
Risk Factors of COVID-19 Associated Mucormycosis (CAM) in Iranian Patients: A Single-Center Retrospective Study.
- Published in:
- Mycopathologia, 2022, v. 187, n. 5/6, p. 469, doi. 10.1007/s11046-022-00670-5
- By:
- Publication type:
- Article
Coexistence of oral lichen planus and pemphigus vulgaris.
- Published in:
- Clinical Oral Investigations, 2018, v. 22, n. 8, p. 2953, doi. 10.1007/s00784-018-2619-3
- By:
- Publication type:
- Article
Drug‐induced cutaneous pseudolymphoma: A systematic review of the literature.
- Published in:
- Australasian Journal of Dermatology, 2023, v. 64, n. 1, p. 41, doi. 10.1111/ajd.13951
- By:
- Publication type:
- Article
Multiple giant milia in cutaneous squamous cell carcinoma: A rare presentation.
- Published in:
- Australasian Journal of Dermatology, 2020, v. 61, n. 2, p. 163, doi. 10.1111/ajd.13180
- By:
- Publication type:
- Article
Otophyma in a woman: A rare and neglected clinicopathological entity.
- Published in:
- Australasian Journal of Dermatology, 2019, v. 60, n. 4, p. e337, doi. 10.1111/ajd.13063
- By:
- Publication type:
- Article
New Insights into the Management of Patients with Autoimmune Diseases or Inflammatory Disorders During Pregnancy.
- Published in:
- Scandinavian Journal of Immunology, 2016, v. 84, n. 3, p. 146, doi. 10.1111/sji.12453
- By:
- Publication type:
- Article
Estimated cut-off values for pemphigus severity classification according to pemphigus disease area index (PDAI), autoimmune bullous skin disorder intensity score (ABSIS), and anti-desmoglein 1 autoantibodies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Rituximab zur Behandlung von Epidermolysis bullosa acquisita: Eine große Fallserie mit 15 Patienten.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2023, v. 21, n. 7, p. 779, doi. 10.1111/ddg.15108_g
- By:
- Publication type:
- Article
Rituximab for the treatment of epidermolysis bullosa acquisita: A large case series of 15 patients.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2023, v. 21, n. 7, p. 779, doi. 10.1111/ddg.15108
- By:
- Publication type:
- Article
Transition between pemphigus vulgaris and pemphigus foliaceus: a 10‐year follow‐up study.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2020, v. 18, n. 11, p. 1302, doi. 10.1111/ddg.14226
- By:
- Publication type:
- Article
Übergang zwischen Pemphigus vulgaris und Pemphigus foliaceus: eine 10‐jährige Follow‐up‐Studie.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2020, v. 18, n. 11, p. 1302, doi. 10.1111/ddg.14226_g
- By:
- Publication type:
- Article
Comparing early and late treatments with rituximab in pemphigus vulgaris: which one is better?
- Published in:
- Archives of Dermatological Research, 2019, v. 311, n. 1, p. 63, doi. 10.1007/s00403-018-1881-1
- By:
- Publication type:
- Article
Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus.
- Published in:
- Archives of Dermatological Research, 2018, v. 310, n. 2, p. 95, doi. 10.1007/s00403-017-1790-8
- By:
- Publication type:
- Article
Elevated serum level of B‐cell activating factor (BAFF) after rituximab therapy in pemphigus vulgaris patients suggests a possible therapeutic efficacy of B‐cell depletion therapies combined with anti‐BAFF agents.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 4, p. 567, doi. 10.1111/ijd.16363
- By:
- Publication type:
- Article
Pustular eruption after biosimilar rituximab infusion: report of acute generalized exanthematous pustulosis in two patients with pemphigus.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 1, p. e14, doi. 10.1111/ijd.15706
- By:
- Publication type:
- Article
Switching from pemphigus vulgaris to psoriasis: a rare report of three cases.
- Published in:
- International Journal of Dermatology, 2020, v. 59, n. 5, p. e144, doi. 10.1111/ijd.14823
- By:
- Publication type:
- Article
Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2024, v. 17, n. 7, p. 24
- By:
- Publication type:
- Article
A comprehensive review of rituximab therapy in rheumatoid arthritis patients.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 11, p. 2977, doi. 10.1007/s10067-019-04699-8
- By:
- Publication type:
- Article
The complex role of macrophages in pancreatic cancer tumor microenvironment: a review on cancer progression and potential therapeutic targets.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01256-x
- By:
- Publication type:
- Article
The complex role of macrophages in pancreatic cancer tumor microenvironment: a review on cancer progression and potential therapeutic targets.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01256-x
- By:
- Publication type:
- Article
Evaluation of the possible association between acantholysis and anti‐desmogleins 1 and 3 values in pemphigus vulgaris and pemphigus foliaceus.
- Published in:
- Journal of Cutaneous Immunology & Allergy, 2019, v. 2, n. 6, p. 169, doi. 10.1002/cia2.12089
- By:
- Publication type:
- Article
Acquired Hemophilia in Association With Pemphigus Vulgaris; An Uncommon Coexistence: A Case Report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
The Efficacy and Safety of Rituximab in ANCA-Associated Vasculitis: A Systematic Review.
- Published in:
- Biology (2079-7737), 2022, v. 11, n. 12, p. 1767, doi. 10.3390/biology11121767
- By:
- Publication type:
- Article
Prevalence and management of chronic hepatitis B in pemphigus and pemphigoid patients: New evidence for the safety of rituximab.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 11, p. 1, doi. 10.1111/dth.15783
- By:
- Publication type:
- Article
Immunological aspects of COVID‐19‐related skin manifestations: Revisiting pathogenic mechanism in the light of new evidence.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15758
- By:
- Publication type:
- Article
Retrospective study of gingival involvement in pemphigus: A difficult to treat phenomenon.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 6, p. 1, doi. 10.1111/dth.15475
- By:
- Publication type:
- Article
Evaluating the risk‐to‐benefit ratio of using cotrimoxazole as a pneumocystis pneumonia preventative intervention among pemphigus patients treated with rituximab: A retrospective study with 494 patients.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 2, p. 1, doi. 10.1111/dth.15257
- By:
- Publication type:
- Article
Rituximab in practice: Clinical evaluation of patients with pemphigus after rituximab administration.
- Published in:
- Dermatologic Therapy, 2021, v. 34, n. 1, p. 1, doi. 10.1111/dth.14633
- By:
- Publication type:
- Article
Concomitant bullous pemphigoid and palmoplantar keratoderma: A report of three cases and review of literature.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 6, p. 1, doi. 10.1111/dth.14481
- By:
- Publication type:
- Article
Investigating expression pattern of eight immune‐related genes in pemphigus patients compared with the healthy controls and after rituximab therapy: Potential roles of CTLA4 and FCGR3A genes expression in outcomes of rituximab therapy.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 6, p. 1, doi. 10.1111/dth.14380
- By:
- Publication type:
- Article
Treatment of pemphigus patients in the COVID‐19 era: A specific focus on rituximab.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 6, p. 1, doi. 10.1111/dth.14188
- By:
- Publication type:
- Article
Decreased serum levels of interleukin‐17, interleukin‐23, TGF‐β in pemphigus vulgaris patients, and their association with disease phase.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 6, p. 1, doi. 10.1111/dth.14071
- By:
- Publication type:
- Article
Desquamative gingivitis in a pemphigus vulgaris patient resistant to rituximab.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 2, p. 1, doi. 10.1111/dth.13225
- By:
- Publication type:
- Article
Iranian guideline for rituximab therapy in pemphigus patients.
- Published in:
- Dermatologic Therapy, 2019, v. 32, n. 5, p. N.PAG, doi. 10.1111/dth.13016
- By:
- Publication type:
- Article
The elevated level of osteopontin in patients with pemphigus vulgaris: A cytokine‐like protein with a therapeutic potential.
- Published in:
- Dermatologic Therapy, 2019, v. 32, n. 4, p. N.PAG, doi. 10.1111/dth.12973
- By:
- Publication type:
- Article
"Change over time in the treatment of pemphigus vulgaris between 2004 and 2016 in Iran": A multiple cross‐sectional study.
- Published in:
- Dermatologic Therapy, 2019, v. 32, n. 2, p. N.PAG, doi. 10.1111/dth.12827
- By:
- Publication type:
- Article
Anti‐desmoglein‐1 levels as predictor of prednisolone tapering in pemphigus vulgaris patients treated with rituximab.
- Published in:
- Dermatologic Therapy, 2018, v. 31, n. 6, p. N.PAG, doi. 10.1111/dth.12671
- By:
- Publication type:
- Article
Tofacitinib as the potent treatment for refractory pemphigus: A possible alternative treatment for pemphigus.
- Published in:
- Dermatologic Therapy, 2018, v. 31, n. 5, p. N.PAG, doi. 10.1111/dth.12696
- By:
- Publication type:
- Article
The ignored roles of micro RNAs in alopecia areata.
- Published in:
- Dermatologic Therapy, 2017, v. 30, n. 4, p. n/a, doi. 10.1111/dth.12488
- By:
- Publication type:
- Article
Dupilumab: a revolutionary emerging drug in atopic dermatitis and its possible role in pemphigus.
- Published in:
- Dermatologic Therapy, 2016, v. 29, n. 5, p. 299, doi. 10.1111/dth.12327
- By:
- Publication type:
- Article
The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature.
- Published in:
- Journal of Research in Medical Sciences, 2016, v. 21, p. 1
- By:
- Publication type:
- Article
Manipulation of Regulatory Cells' Responses to Treatments for Chronic Hepatitis B Virus Infection.
- Published in:
- Hepatitis Monthly, 2016, v. 16, n. 6, p. 1, doi. 10.5812/hepatmon.37927
- By:
- Publication type:
- Article
Tumor Necrosis Factor-α-308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-Analysis.
- Published in:
- Hepatitis Monthly, 2016, v. 16, n. 4, p. 1, doi. 10.5812/hepatmon.33537
- By:
- Publication type:
- Article
Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-Screened.
- Published in:
- Hepatitis Monthly, 2016, v. 16, n. 4, p. 1, doi. 10.5812/hepatmon.35810
- By:
- Publication type:
- Article
Association of Plasma Levels of Vitamin D With Chronic Hepatitis B Infection.
- Published in:
- Hepatitis Monthly, 2016, v. 16, n. 1, p. 1, doi. 10.5812/hepatmon.35525
- By:
- Publication type:
- Article